OpenVSafe by OpenVAERS
Search V-safe

SSW-16870-49266

3 vaccinations 5 coded responses 24 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
067 / CT
Registered
2021-04-22
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-22
    Registered in v-safe
  2. 2021-04-22
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-22
    Health check-in — day 0, dose 1
    Feeling: Fair · Nausea
    Adult check-in
  4. 2021-04-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-04-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-04-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  7. 2021-04-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  8. 2021-04-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-29
    Health check-in — day 7, dose 1
    Feeling: Good · Joint pains, Muscle or body aches
    Adult check-in
  11. 2021-05-06
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-05-14
    Dose 2 — Pfizer-BioNTech
  13. 2021-05-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hyperhidrosis — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Sweats
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  15. 2021-05-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Diarrhea
    Adult check-in
  16. 2021-05-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Joint pains, Fatigue or tiredness
    Adult check-in
  17. 2021-05-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  18. 2021-05-21
    Health check-in — day 7, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  19. 2021-05-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-06-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-06-11
    Survey response — day 28, dose 2
    MedDRA: Tachycardia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Tachycardia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-06-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-25
    Survey response — day 42, dose 2
    MedDRA: Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Heart tachycardia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-06-25
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-06-30
  26. 2021-07-06
  27. 2021-08-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-03-16
    Dose 3 — Pfizer-BioNTech
  29. 2022-06-16
    Survey response — 3 months, dose 3
    MedDRA: Migraine, Seizure — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Increased migraine frequency & suspected seizure activity
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-06-16
    Report sent to call center — 3 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  31. 2022-06-16
  32. 2022-06-16
  33. 2022-09-16
    Survey response — 6 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Had covid
    MedDRA releases: 2024-11 · check-in free text available
  34. 2023-03-17
    Health check-in — 12 months, dose 3
    Feeling: Poor
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-22Pfizer-BioNTech
22021-05-14Pfizer-BioNTech
32022-03-16Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-16

Systemic reaction (other): Sweats

Release 9 — day 28, dose 2

2021-06-11

Symptoms: Tachycardia

Release 9 — day 42, dose 2

2021-06-25

Symptoms: Heart tachycardia

Release 12 — 3 months, dose 3

2022-06-16

Symptoms: Increased migraine frequency & suspected seizure activity

Release 12 — 6 months, dose 3

2022-09-16

Symptoms: Had covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDMigraine · · ✓
SDSeizure · · ✓
SDTachycardia ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…